—ABATE Phase 2 Trial Aims to Further Assess Safety and Establish Biological and Clinical Proof-of-Concept for CM-101 as a Potential Treatment for Patients with Systemic Sclerosis— CM-101 is a first-in ...
Chemomab Therapeutics, Ltd. (Chemomab), a clinical-stage biotech company, announced that the US Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results